Multi-institutional phase 2 study of TLK286 (TELCYTA, a glutathione S-transferase P1-1 activated glutathione analog prodrug) in patients with platinum and paclitaxel refractory or resistant ovarian cancer (Q46598239)
scientific article published in July 2005
Language:
(P31) (Q13442814)
(P304) 593-600
(P433) 4
(P478) 15
(P577) Friday, July 1, 2005
(P921) (Q172341)
(Q116907)
(Q423762)
(P1433) (Q15749181)
(P1476) "Multi-institutional phase 2 study of TLK286 (TELCYTA, a glutathione S-transferase P1-1 activated glutathione analog prodrug) in patients with platinum and paclitaxel refractory or resistant ovarian cancer" (language: en)
(P2093) Kavanagh JJ
Gershenson DM
Choi H
Lewis L
Patel K
Brown GL
Garcia A
Spriggs DR
other details
description scientific article published in July 2005

External Links